FIELD: chemical-pharmaceutical industry; medicine; pharmacology.
SUBSTANCE: antidiabetic composition contains the following components in g/sachet (wt.%): gliclazide 0.06 (1.6), Galega officinalis herb extract 0.10 (2.6), liquorice root extract 0.60 (16.0), peppermint herb extract 0.30 (8.0), apple pectin 2.00 (53.2), hydroxyethyl cellulose 0.50 (13.3), solution of kollidon K-30 in ethyl alcohol 0.20 (5.3).
EFFECT: invention provides creation of a pharmaceutical composition of antidiabetic action of a complex formulation, made in the form of a sachet, containing gliclazide and its softening side effects dry extracts of Galega officinalis, licorice root, peppermint.
1 cl, 3 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION OF ANTIDIABETIC ACTION IN SOLID DOSAGE FORM IN THE FORM OF TABLETS | 2022 |
|
RU2801279C1 |
AGENT FOR PREVENTING AND TREATING INSULIN-INDEPENDENT DIABETES | 2011 |
|
RU2458701C1 |
COMPOSITION POSSESSING MULTICOMPONENT MECHANISM OF ANTIDIABETIC EFFECT | 2004 |
|
RU2289419C2 |
SOLID DOSED FORMULATION FOR TREATMENT OF PANCREATIC DIABETES | 2006 |
|
RU2333760C2 |
COMPOSITION POSSESSING ANTIDIABETIC ACTION | 2015 |
|
RU2611353C2 |
METHOD FOR CORRECTION OF POST-PRANDIAL GLYCEMIA | 2022 |
|
RU2805492C9 |
ANTIDIABETIC COMPOSITION | 2009 |
|
RU2430735C1 |
ANTIDIABETIC SPECIES | 2004 |
|
RU2284829C2 |
SOLIDPHASE COMPOSITION OF NATURAL BIOACTIVE INGREDIENTS FOR CORRECTION OF METABOLIC DISTURBANCES IN DIABETES MELLITUS TYPE II | 2017 |
|
RU2661622C1 |
SOLID UNIT DOSAGE FORM FOR PANCREATIC DIABETES | 2009 |
|
RU2380097C1 |
Authors
Dates
2024-04-11—Published
2023-04-03—Filed